Scholarlink

Rationale <p>Apocynin–tandospirone derivatives (ATDs) have recently been shown to ameliorate methamphetamine (MAP)-induced behavioral abnormalities when administered chronically, presumably through antioxidant and interneuron–related mechanisms. However, their acute behavioral profile remains unclear.</p> Objective <p>In this study, we examined whether acute ATD administration exerts antipsychotic-like effects in rats.</p> Methods <p>Rats received acute treatment with ATDs (<b>A-2</b>, <b>A-3</b>, <b>A-4</b>), atypical antipsychotics, or saline, followed by assessments of spontaneous locomotor activity and MAP-induced hyperlocomotion. Prepulse inhibition (PPI), dopamine (DA) concentrations in the medial prefrontal cortex (mPFC) and nucleus accumbens (NAC) were also measured.</p> Results <p>Acute ATD administration did not reduce spontaneous activity and failed to suppress MAP-induced hyperlocomotion. Instead, all three ATDs significantly enhanced MAP-induced locomotor responses, with <b>A-3</b> showing dose-dependent potentiation. ATDs did not improve MAP-induced PPI deficits, except for a modest effect of high-dose <b>A-3</b>. Consistent with these behavioral outcomes, DA levels in the NAC were unchanged, and only small increases in mPFC DA were observed with <b>A-2</b> and high-dose <b>A-3</b>.</p> Conclusion <p>The results demonstrate that acute ATD administration neither suppressed MAP-induced behavioral abnormalities nor produced marked neurochemical changes, but instead enhanced MAP-induced locomotor activity, indicating a clear dissociation from their previously reported chronic effects.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Acute apocynin-tandospirone derivatives (ATDs) exacerbate methamphetamine-induced hyperlocomotion in rats

  • 期刊论文

  • 发表日期：

    2026年3月5日

查看全文
  • Takashi Uehara,
  • Hiroko Itoh,
  • Hitoshi Abe,
  • Yuzuru Kataoka,
  • Takanori Senoo,
  • Tatsuya Nagasawa,
  • Michio Suzuki

摘要

Rationale

Apocynin–tandospirone derivatives (ATDs) have recently been shown to ameliorate methamphetamine (MAP)-induced behavioral abnormalities when administered chronically, presumably through antioxidant and interneuron–related mechanisms. However, their acute behavioral profile remains unclear.

Objective

In this study, we examined whether acute ATD administration exerts antipsychotic-like effects in rats.

Methods

Rats received acute treatment with ATDs (A-2, A-3, A-4), atypical antipsychotics, or saline, followed by assessments of spontaneous locomotor activity and MAP-induced hyperlocomotion. Prepulse inhibition (PPI), dopamine (DA) concentrations in the medial prefrontal cortex (mPFC) and nucleus accumbens (NAC) were also measured.

Results

Acute ATD administration did not reduce spontaneous activity and failed to suppress MAP-induced hyperlocomotion. Instead, all three ATDs significantly enhanced MAP-induced locomotor responses, with A-3 showing dose-dependent potentiation. ATDs did not improve MAP-induced PPI deficits, except for a modest effect of high-dose A-3. Consistent with these behavioral outcomes, DA levels in the NAC were unchanged, and only small increases in mPFC DA were observed with A-2 and high-dose A-3.

Conclusion

The results demonstrate that acute ATD administration neither suppressed MAP-induced behavioral abnormalities nor produced marked neurochemical changes, but instead enhanced MAP-induced locomotor activity, indicating a clear dissociation from their previously reported chronic effects.